Cargando…
LC3B globular structures correlate with survival in esophageal adenocarcinoma
BACKGROUND: Esophageal adenocarcinoma has the fastest growing incidence of any solid tumor in the Western world. Prognosis remains poor with overall five-year survival rates under 25 %. Only a limited number of patients benefit from chemotherapy and there are no biomarkers that can predict outcome....
Autores principales: | El-Mashed, Shereen, O’Donovan, Tracey R., Kay, Elaine W., Abdallah, Ayat R., Cathcart, Mary-Clare, O’Sullivan, Jacintha, O’Grady, Anthony, Reynolds, John, O’Reilly, Seamus, O’Sullivan, Gerald C., McKenna, Sharon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533787/ https://www.ncbi.nlm.nih.gov/pubmed/26265176 http://dx.doi.org/10.1186/s12885-015-1574-5 |
Ejemplares similares
-
Correction to: LC3B globular structures correlate with survival in esophageal adenocarcinoma
por: El-Mashed, Shereen, et al.
Publicado: (2019) -
Lithium Modulates Autophagy in Esophageal and Colorectal Cancer Cells and Enhances the Efficacy of Therapeutic Agents In Vitro and In Vivo
por: O’Donovan, Tracey R., et al.
Publicado: (2015) -
UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells
por: Falvey, Chloe M., et al.
Publicado: (2017) -
Correction: UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells
por: Falvey, Chloe M., et al.
Publicado: (2020) -
Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients
por: El Mashed, Shereen, et al.
Publicado: (2022)